| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Mar 18, 2024 | Sale | $56.90 | 9,913 | 564,050 | 54,693 | Mar 19, 2024, 04:03 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 12, 2024 | Sale | $67.77 | 597 | 40,457 | 64,606 | Feb 13, 2024, 04:38 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 29, 2024 | Sale | $64.14 | 367 | 23,539 | 65,203 | Jan 31, 2024, 04:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 22, 2024 | Sale | $65.00 | 1,384 | 89,954 | 65,570 | Jan 23, 2024, 06:01 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 16, 2024 | Sale | $66.81 | 1,631 | 108,965 | 66,954 | Jan 17, 2024, 04:41 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Oct 23, 2023 | Sale | $46.04 | 131 | 6,031 | 51,622 | Oct 24, 2023, 04:18 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 21, 2023 | Option Exercise | $58.50 | 441 | 25,799 | 51,341 | Feb 22, 2023, 06:46 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Feb 10, 2023 | Option Exercise | $51.21 | 670 | 34,311 | 46,502 | Feb 14, 2023, 04:24 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 27, 2023 | Option Exercise | $52.77 | 367 | 19,367 | 47,172 | Jan 30, 2023, 04:45 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Chief Business & Strat Officer | Jan 20, 2023 | Option Exercise | $52.05 | 1,149 | 59,805 | 47,539 | Jan 24, 2023, 05:12 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Oct 20, 2022 | Option Exercise | $58.00 | 196 | 11,368 | 29,054 | Oct 24, 2022, 05:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 17, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Aug 18, 2022, 04:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 17, 2022 | Sale | $69.50 | 5,000 | 347,500 | 29,250 | Aug 18, 2022, 04:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 11, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Aug 12, 2022, 04:58 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 11, 2022 | Sale | $67.00 | 5,000 | 335,000 | 29,250 | Aug 12, 2022, 04:58 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 08, 2022 | Sale | $64.50 | 5,000 | 322,500 | 29,250 | Aug 09, 2022, 05:16 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 08, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Aug 09, 2022, 05:16 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 04, 2022 | Option Exercise | $15.52 | 10,000 | 155,200 | 39,250 | Aug 08, 2022, 04:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Aug 04, 2022 | Sale | $60.75 | 10,000 | 607,500 | 34,250 | Aug 08, 2022, 04:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 27, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Jul 28, 2022, 04:03 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 27, 2022 | Sale | $57.00 | 5,000 | 285,000 | 29,250 | Jul 28, 2022, 04:03 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 19, 2022 | Sale | $56.42 | 5,000 | 282,100 | 29,250 | Jul 21, 2022, 04:31 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 19, 2022 | Option Exercise | $15.52 | 5,000 | 77,600 | 34,250 | Jul 21, 2022, 04:31 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jun 16, 2022 | Option Exercise | $13.85 | 10,000 | 138,500 | 39,250 | Jun 21, 2022, 04:11 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jun 16, 2022 | Sale | $41.78 | 10,000 | 417,850 | 29,250 | Jun 21, 2022, 04:11 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Apr 20, 2022 | Option Exercise | $15.52 | 7,000 | 108,640 | 35,481 | Apr 22, 2022, 05:35 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Apr 20, 2022 | Sale | $52.53 | 7,000 | 367,710 | 28,481 | Apr 22, 2022, 05:35 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jan 28, 2022 | Option Exercise | $38.59 | 434 | 16,748 | 20,530 | Feb 01, 2022, 06:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 21, 2021 | Option Exercise | $15.52 | 1,000 | 15,520 | 10,490 | Jul 22, 2021, 04:24 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 21, 2021 | Sale | $65.00 | 1,000 | 65,000 | 9,490 | Jul 22, 2021, 04:24 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 15, 2021 | Option Exercise | $15.52 | 1,000 | 15,520 | 10,490 | Jul 16, 2021, 06:40 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | DeLong Mark Jeffrey | Senior Vice President | Jul 15, 2021 | Sale | $62.30 | 1,000 | 62,300 | 9,490 | Jul 16, 2021, 06:40 PM |
Menu